Skip to content
PeptideRank
MintRx logo

Provider review

MintRx cost: $343/mo sermorelin

Its sermorelin headline understates the real monthly price by 16%.

MintRx's own sermorelin page headlines "From $295," then discloses "Billed and shipped monthly. $343 per month" further down the same page — a real, disclosed $48/mo gap once a reader reads the whole page, not a hidden one.

Verified August 2026

Reviewed by Marcus Webb

Transparency scorecard

2 of 4 disclosed openly

What MintRx discloses about itself, read from its own pages — not estimated.

Pharmacy named & regulated

Not disclosed

Does not name a pharmacy or state a regulatory category anywhere on its own site.

State coverage published

Disclosed

Publishes which states it actually serves.

A real price is published

Disclosed

A real dollar figure is published on its own site, not estimated.

No hidden commitment trap

Not disclosed

The advertised price requires a prepay, auto-refill, or other commitment we found and named.

This review's stake, stated plainlysome of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

At a glance

Visit MintRx

Pharmacy

Not categorized

Labs

Not stated.

States

Published state list

On this page

What it actually costs

What this price covers

Medication

Included

Provider visits

Included

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Not disclosed

The catch — Sermorelin's "From $295" headline sits $48/month (16%) below the "$343 per month" figure the same page discloses as the real, billed-and-shipped-monthly rate.

See plans at MintRx

Prices read from MintRx's own site · August 2026

What they advertise

Sermorelin "From $295"; PT-141 "$160 first month, then $180/mo"; NAD+ "$195 first month, $225/mo after" (or $585 billed quarterly for a 3-month plan).

What you actually pay

Sermorelin's real, billed-and-shipped-monthly rate is $343/mo, disclosed on the same page as the "From $295" headline. PT-141's real standing rate is $180/mo. NAD+'s real standing rate is $225/mo, both disclosed transparently beside their first-month figures.

The bottom line

MintRx (mintrx.com) is a real, high-volume telehealth pharmacy storefront (2,000+ Trustpilot reviews) selling compounded PT-141, sermorelin and NAD+. It publishes no price for compounded tirzepatide or compounded semaglutide.

MintRx appears on our sermorelin provider ranking, our NAD+ provider ranking and our PT-141 provider ranking. Nothing on this page is a performance claim.

Who it is for, and who it is not

A good fit if

  • You want a dispensing pharmacy named directly, not just a generic "licensed pharmacy" claim.
  • You want a LegitScript seal you can independently verify resolves, not just a badge image.
  • You want a specific, positive state-availability list rather than a vague nationwide claim.

Look elsewhere if

  • You want the headline price to BE the standing price — MintRx's sermorelin and PT-141 headlines both step up after the first month.
  • A stated 503A/503B regulatory category is what you're after — MintRx names its pharmacy but never states a category for it.
  • Every legal/contact detail on the site to hold together is worth something to you — its own Contact page names a UK office address on an otherwise entirely US-facing site.

What MintRx offers

Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.

Who fills your prescription

No category stated

MintRx does not name the pharmacy that fills your prescription.

What its own site says

Unknown regulatory category. MintRx's own footer names a specific dispensing pharmacy via a BBB Business Review seal — "Medmetrics Compounding Pharmacy" (Chandler, AZ) — plus a LegitScript seal (ID 1056826, confirmed against LegitScript's own registry) — but neither "503A" nor "503B" is stated anywhere on the site checked.

What's the difference between 503A and 503B?

A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.

Where you can get it

Published state list

List published. The state dropdown on MintRx's own PT-141 intake form lists 34 states plus DC — a real, specific, positive list, not an "all 50" claim.

The honest cons

The part they would rather you skipped

MintRx's own sermorelin page headlines "From $295," undermining the real "$343 per month" standing rate the same page discloses further down — a $48/mo, 16% gap. Its own live Contact page also names a UK office address ("2281 New Way Street, London, United Kingdom") on an otherwise entirely US-facing site (US state dropdown, US phone numbers, US pharmacy) — a discrepancy the site never explains. FDA has issued no warning letter to MintRx.

  • The "From $295" sermorelin headline understates the real $343/mo standing rate by 16%.
  • No 503A/503B category is stated anywhere on the site, despite naming its pharmacy.
  • Its own Contact page names a UK office address that does not match the rest of the site's entirely US-facing presentation.

None of this is unique to MintRx — the whole category shares it.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Ready to get started?

Prices and plans in this category change often — check MintRx's current pricing before you decide. Ours was read from their own site in August 2026.

See MintRx pricing

Facts on this page reflect MintRx's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on MintRx's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.

MintRx

3 compounds from $180/mo

Visit